COLIN P DINNEY to Patient Selection
This is a "connection" page, showing publications COLIN P DINNEY has written about Patient Selection.
Connection Strength
0.563
-
Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7.
Score: 0.265
-
Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer. JAMA Oncol. 2019 12 01; 5(12):1790-1798.
Score: 0.103
-
Targeted therapies in bladder cancer--an update. Urol Oncol. 2007 Sep-Oct; 25(5):433-8.
Score: 0.044
-
If cystectomy is insufficient, what is an urologist to do? Urol Oncol. 2003 Nov-Dec; 21(6):475-8.
Score: 0.034
-
Progression of Disease after Bacillus Calmette-Gu?rin Therapy: Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy. J Urol. 2021 11; 206(5):1258-1267.
Score: 0.029
-
Timely delivery of biological therapy after cytoreductive nephrectomy in carefully selected patients with metastatic renal cell carcinoma. J Urol. 1998 Apr; 159(4):1168-73.
Score: 0.023
-
Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer. Urol Oncol. 2016 10; 34(10):469-76.
Score: 0.020
-
The role of chemotherapy in the management of the patient with T3b bladder cancer. Semin Urol Oncol. 1996 May; 14(2):81-5.
Score: 0.020
-
Controversies in ilioinguinal lymphadenectomy. Urol Clin North Am. 2010 Aug; 37(3):421-34.
Score: 0.013
-
Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology. 2007 Sep; 70(3):473-6.
Score: 0.011